MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
3.740
+0.190 (5.35%)
At close: Oct 9, 2026, 4:00 PM EDT
3.800
+0.060 (1.60%)
After-hours: Oct 9, 2026, 7:35 PM EDT

MacroGenics Revenue

MacroGenics had revenue of $32.83M in the quarter ending June 30, 2026, with 377.97% growth. This brings the company's revenue in the last twelve months to $167.67M, up 11.69% year-over-year. In the year 2025, MacroGenics had annual revenue of $149.50M, down -0.31%. That makes MacroGenics the 18,411th largest company in the world by revenue and 2,966th in the United States.

Revenue (ttm)
$167.67M
Revenue Growth
+11.69%
P/S Ratio
1.36
Revenue / Employee
$597,754
Employees
293
Market Cap
238.24M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025149.50M-462.00K-0.31%
Dec 31, 2024149.96M91.21M155.26%
Dec 31, 202358.75M-93.19M-61.33%
Dec 31, 2022151.94M74.49M96.19%
Dec 31, 202177.45M-27.44M-26.16%
Dec 31, 2020104.88M40.70M63.40%
Dec 31, 201964.19M4.07M6.76%
Dec 31, 201860.12M-97.62M-61.89%
Dec 31, 2017157.74M65.86M71.68%
Dec 31, 201691.88M-8.97M-8.90%
Dec 31, 2015100.85M53.06M111.00%
Dec 31, 201447.80M-10.24M-17.64%
Dec 31, 201358.04M-5.79M-9.07%
Dec 31, 201263.83M6.62M11.57%
Dec 31, 201157.21M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Q32 Bio53.74M
Sutro Biopharma45.70M
ProQR Therapeutics21.05M
Keros Therapeutics15.01M
Alector13.86M
Pyxis Oncology11.04M
Evommune10.00M
Camp4 Therapeutics4.22M
Revenue Rankings